Please join us for a special discussion on the development, manufacturing, and analysis of DNA & RNA therapeutics utilizing both cell-based and cell-free processes. This includes the raw materials necessary for in vitro replication and/or transcription with a focus on the acquisition of high-quality nucleotides and recombinant enzymes. The meeting will also consider drug product formulations and nanoparticle delivery systems, including the associated raw materials, with lipids as a particular focus.